3554
J . Org. Chem. 1999, 64, 3554-3556
Syn th esis of a Glycolip id ic Am p h ip h ilic Nitr on e a s a New Sp in
Tr a p
Olivier Ouari,†,‡ Ange Polidori,† Bernard Pucci,*,†,§ Paul Tordo,‡ and Florence Chalier*,‡,|
Laboratoire “Chimie Bioorganique et des Syste`mes Mole´culaires Vectoriels”, Universite´ d’Avignon et des
Pays du Vaucluse, Faculte´ des Sciences, 33, rue Louis Pasteur, 84000-Avignon, France, and
Laboratoire “Structure et Re´activite´ des Espe`ces Paramagne´tiques”, UMR 6517, CNRS et Universite´s
d’Aix-Marseille I et III, Faculte´ de Saint J e´roˆme, case 521, 13397 Marseille Cedex 20, France
Received November 30, 1998
The synthesis of a new amphiphilic nitrone, A, derived from a digalactosyl tris(hydroxymethyl)-
aminomethane bearing a perfluorocarbon chain is described. A exhibited a surfactant behavior
(cmc ) 1.6 × 10-5 mol/L), and the specific recognition of the galactosyl moiety grafted on A by the
KbCWL1 membrane lectin was established. Preliminary experiments showed that A was able to
trap free radicals in aqueous media, the shape of the observed ESR spectra being strongly dependent
upon the nature of the trapped free radical.
Sch em e 1
The spin trapping technique coupled with ESR has
emerged as one of the most useful tools to investigate
the implication of short-lived free radicals in several
clinical disorders.1 Nitrones are the most appropriate spin
traps used in biological systems,2 and among them
R-phenyl-N-tert-butylnitrone (PBN)3 and the 5,5-dimeth-
ylpyrroline N-oxide (DMPO)4 are still the most popular.
In a biological milieu, free radicals can decay by
enzymatic or chemical reactions and their concentrations
always remain very small. This is particularly true in
the case of the superoxide radical in the presence of
superoxide dismutase (SOD) or for the hydroxyl radical
which reacts quickly with most of the biocomponents. To
improve the efficiency of the spin trapping in biological
systems, control of the delivery of the spin trap on the
spot of the radical event is very important. To ensure a
suitable pharmacomodulation, one of the possibilities is
to graft the trapping agent on a natural or a synthetic
carrier. This carrier could modify the hydro- or lipophi-
licity of the active principle and thus would modulate its
membrane crossing ability. Furthermore, it could ensure
specific cell targeting via its functionalization with
ligands such as antibodies, peptides, or carbohydrates.5
As part of our program dealing with the vectorization
and the cell targeting of spin traps,6 we designed a new
glycosidic amphiphilic nitrone, A, derived from PBN
(Scheme 1). The nitronyl group grafted to the tris amino
group by a peptidic spacer arm will ensure the spin
trapping function, and the hydrophilic galactosyl groups
should achieve targeting via specific recognition by
membrane lectins. After iv or ip injections into rats,
amphiphilic fluorocarbon telomers derived from tris-
(hydroxymethyl)aminomethane (Tris) and bearing per-
fluorocarbon chain were detected in all organs.7 Further-
more, in vitro, these compounds easily cross the plasma
membrane,8 and it is thus reasonable to think that A can
cross cell membranes. We report hereafter the synthesis
of A, and some preliminary results on its trapping ability
and its recognition by specific membrane lectins.
The synthesis of A was performed as reported in
Scheme 2. The glycine derivative 1 was obtained by
reaction of Z-protected glycine with Tris in the presence
of 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ)
as a coupling reagent in refluxing ethanol. Acetalization
of two hydroxyl functions of the Tris group was carried
out by treatment with 2,2-dimethoxypropane in acetoni-
trile to yield 1 in 75% yield. The perfluorocarbon chain
was then introduced by reacting 1 with the corresponding
perfluorocarbon isocyanate in the presence of DABCO
followed by hydrolysis of the acetal by Montmorillonite
K10 resin,9 leading to 2 in 81% yield. Glycosylation of
§ Telephone: (33) 4 90 14 44 42. Fax: (33) 4 91 14 44 49. e-mail:
pucci@univ-avignon.fr.
| Telephone: (33) 4 91 28 85 62. Fax: (33) 4 91 28 85 12. e-mail:
chalier@srepir1.univ-mrs.fr.
† Universite´ d’Avignon et des Pays du Vaucluse.
‡ CNRS et Universite´s d’Aix-Marseille I et III.
(1) Finkelstein, E.; Rosen, G. M.; Rauckman, E. J . Arch. Biochem.
Biophys. 1980, 200, 1. Rosen, G. M.; Finkelstein, E. Adv. Free Rad.
Biol. Med. 1985, 1, 345.
(2) Halliwell, B.; Gutteridge, J . M. C. Free Radicals in Biology and
Medicine; Clarendon Press: Oxford, 1989; Chapter 2, p 47. DeGray, J .
A.; Mason, R. P. Biological Spin Trapping. In Electron Spin Resonance;
Atherton, N. M., Davies, M. J ., Gilbert, B. C., Eds.; Athenaeum Press
Ltd.: Cambridge, 1994; Vol. 14, pp 246-301. Thornalley, P. J . Life
Chem. Rep. 1986, 4, 57.
(3) Lai, E. K.; McCay, P. B.; Noguchi, T.; Fong, K. L. Biochem.
Pharm. 1979, 28, 2231. Shridhar, R.; Beaumont, P. C.; Powers, E. L.
J . Radioanal. Nuclear Chem. 1986, 101, 227. Kotake, Y.; J anzen, E.
G. J . Am. Chem. Soc. 1991, 113, 9503. J anzen, E. G.; Kotake, Y.;
Hinton, R. D. Free Rad. Biol. Med. 1992, 12, 169.
(4) Finkelstein, E.; Rosen, G. M.; Rauckman, E. J . J . Am. Chem.
Soc. 1980, 102, 4994. Samuni, A.; Murali Krishna, C.; Riesz, P.;
Finkelstein, E.; Russo, A. Free Rad. Biol. Med. 1989, 6, 141.
(5) Ringsdorf, H.; Schlarb, B.; Venzmer, J . Angew. Chem., Int. Ed.
Engl. 1988, 27, 113. Dacho, Y.; Okada, S.; Gotto, R. Biochim. Biophys.
Acta 1991, 1107, 61.
(6) Ouari, O.; Chalier, F.; Pucci, B.; Tordo, P. J . Chem. Soc., Perkin
Trans. 2 1998, 2299.
(7) Maurizis, J . C.; Azim, M.; Rapp, M.; Pucci, B.; Pavia, A. A.;
Madelmont, J . C.; Veyre, A. Xenobiotica 1994, 24, 1183.
(8) Chehade, F.; Maurizis, J . C.; Pucci, B.; Pavia, A. A.; Ollier, M.;
Veyre, A.; Escaig, F.; J eanguillaume, C.; Dennebouy, R.; Slodzian, G.;
Hindie, E. Cell. Mol. Biol. 1996, 42, 335.
(9) Gautier, E.; Graham, A.; McKillop, A.; Standen, S.; Taylor, R.
Tetrahedron Lett. 1997, 38, 1881.
10.1021/jo982343+ CCC: $18.00 © 1999 American Chemical Society
Published on Web 04/24/1999